Infosys’s arm, Simplus announces Vaccine Management Solution with Salesforce
Infosys’s arm, Simplus announced on Thursday post trading session that it has collaborated with Salesforce a cloud solution built on the Salesforce Platform for vaccine management. With Simplus’ resources, capabilities coupled with consulting and product expertise of Salesforce, the companies have created an end-to-end vaccine management solution.
Infosys vaccine management solution built on the Salesforce Platform covers a large spectrum of vaccine management, including citizen registration, prioritization, vaccine administration, wellness surveys and so on. The company brings an integrated solution that can meet the demands of rigorous and expansive vaccine management programs.
Location-wise, company garners 60.5 per cent of its revenue from North America, 24.1 per cent from Europe, 2.5 per from India and 12.9 per cent from rest of the world.
The stock on Friday closed up by 0.60 per cent at Rs 1,103. In comparison, S&P BSE SENSEX closed 0.65 per cent. Infosys Ltd. recorded a 52-week high of Rs 1,185 and a 52-week low of Rs 511.1 on BSE.